A postmarketing study for the drug, which is supposed to reduce the risk of preterm birth, failed to substantiate any clinical benefit or effect on gestational age at delivery, the agency said.
News Alerts
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
